Showing results (251-260 of 291) with videos related to
Sort By:
Pageof 30
Blood Advances|November 27, 2024
Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUMKrzysztof Kalwak, Laura M Moser, Ulrike Pötschger, et al.Bone Marrow Transplantation|May 19, 2026
The impact of pre-transplant extramedullary disease on the outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in children- on behalf of PDWP/EBMTJuliana Silva, Jacques-Emmanuel Galimard, Jean-Hugues Dalle, et al.Bone Marrow Transplantation|August 1, 2019
Prognostic impact of EBV serostatus in patients with lymphomas or chronic malignancies undergoing allogeneic HCTJan Styczynski, Gloria Tridello, Lidia Gil, et al.Bone Marrow Transplantation|July 10, 2021
Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndromeRachel Bortnick, Marcin Wlodarski, Valerie de Haas, et al.Blood Advances|October 25, 2019
Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targetsJessica I Hoell, Sebastian Ginzel, Michaela Kuhlen, et al.Bone Marrow Transplantation|October 29, 2025
Comparison of outcomes of BuCy versus BuCyMel as preparation for allogeneic HSCT in infants with acute myeloid leukemia in first complete remission: a multicenter study from the EBMT PDWPAndre Manfred Willasch, Claire Horgan, Christina Peters, et al.Bone Marrow Transplantation|July 27, 2026
Late complications after autologous HSCT for autoimmune diseases: a retrospective survey from the autoimmune diseases working party (ADWP), transplant complications working party (TCWP) and paediatric diseases working party (PDWP) of the european society for blood and marrow transplantation (EBMT)Kirill Kirgizov, Raffaella Greco, Manuela Badoglio, et al.Leukemia|November 27, 2019
Correction: Hematopoietic stem cell transplantation for children with acute myeloid leukemia-results of the AML SCT-BFM 2007 trialMartin G Sauer, Peter J Lang, Michael H Albert, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2026
Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALLStephan A Grupp, Shannon L Maude, Susana Rives, et al.Journal for Immunotherapy of Cancer|August 6, 2021
Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemiaJohn E Levine, Stephan A Grupp, Michael A Pulsipher, et al.Pageof 30